1. Shanmugaraj, B, Siriwattananon, K, Wangkanont, K, Phoolcharoen, W, Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol, 2020, 38, 10-18. DOI 10.12932/AP-200220-0773
2. Fehr, A.R, Perlman, S, Coronaviruses: an overview of their replication and pathogenesis. Methods in molecular biology (Clifton, N.J.), 2015, 1282, 1–23. DOI: 10.1007 / 978-1-4939-2438-7_1.
3. Chen, W.H, Strych, U, Hotez, P.J, Bottazzi, M.E, The SARS-CoV-2 Vaccine Pipeline: an Overview, Current tropical medicine reports, 2020, 7, 1-4. DOI: 10.1007 / s40475-020-00201-6
4. Lu, R, Zhao, X, Li, J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020, 395, 565-574. DOI: https://doi.org/10.1016/S0140-6736(20)30251-8.
5. World Health Organization Press Conference 2020 The World Health Organization (WHO) Has Officially Named the Disease Caused by the Novel Coronavirus as COVID-19. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_4, 2020 Erişim Tarihi: 30 Nisan 2020.